### [2014-08-24](/news/2014/08/24/index.md)

# Swiss drugmaker Hoffmann-La Roche agrees to acquire American drugmaker InterMune for $8.3 billion. 




### Source:

1. [San Francisco Chronicle](http://www.sfgate.com/news/article/Roche-buys-Brisbane-drugmaker-InterMune-for-8-3-5709455.php)

### Related:

1. [The U.S. Food and Drug Administration (FDA) approves Kadcyla, a new drug manufactured by Roche, for treating late-stage breast cancer. ](/news/2013/02/22/the-u-s-food-and-drug-administration-fda-approves-kadcyla-a-new-drug-manufactured-by-roche-for-treating-late-stage-breast-cancer.md) _Context: Hoffmann-La Roche_
2. [Cipla does not infringe a valid Roche patent on erlotinib (trade name ''Tarceva'') for the production of its generic cancer drug Erlocip, says the Delhi High Court. ](/news/2012/09/7/cipla-does-not-infringe-a-valid-roche-patent-on-erlotinib-trade-name-tarceva-for-the-production-of-its-generic-cancer-drug-erlocip-sa.md) _Context: Hoffmann-La Roche_
